Find Obefazimod manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Abx-464, Abx464, Obefazimod, 1258453-75-6, Spl-464, Obefazimod [usan]
Molecular Formula
C16H10ClF3N2O
Molecular Weight
338.71  g/mol
InChI Key
OZOGDCZJYVSUBR-UHFFFAOYSA-N
FDA UNII
26RU378B9V

Obefazimod
Obefazimod is an orally available, small molecule binder of the cap binding complex (CBC) 80/20, with potential antiviral and anti-inflammatory activities. Upon oral administration, obefazimod binds to the CBC, a complex at the 5'-end of the pre-mRNA transcript that promotes the initial interaction with transcription and processing machinery. This leads to a conformational change in the CBC and enhanced splicing of viral RNA variants and upregulation of the anti-inflammatory microRNA, miR-124, via splicing of a long noncoding RNA at the miR-124-1 locus. In human immunodeficiency virus type 1 (HIV-1)-infected cells, obefazimod interacts with the CBC of HIV-1 mRNA and inhibits viral replication by preventing Rev-mediated export of unspliced HIV-1 transcripts to the cytoplasm. Rev facilitates the nuclear export of unspliced or incompletely spliced viral pre-mRNAs, an essential step in HIV-1 replication. In inflammatory conditions, miR-124 reduces the production of various inflammatory mediators, including interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha), and C-C motif chemokine 2 (CCL2; MCP-1.). miR-124 plays a critical role in innate and adaptive immune responses and is a critical mediator of cholinergic anti-inflammatory action.
1 2D Structure

Obefazimod

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
8-chloro-N-[4-(trifluoromethoxy)phenyl]quinolin-2-amine
2.1.2 InChI
InChI=1S/C16H10ClF3N2O/c17-13-3-1-2-10-4-9-14(22-15(10)13)21-11-5-7-12(8-6-11)23-16(18,19)20/h1-9H,(H,21,22)
2.1.3 InChI Key
OZOGDCZJYVSUBR-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=CC2=C(C(=C1)Cl)N=C(C=C2)NC3=CC=C(C=C3)OC(F)(F)F
2.2 Other Identifiers
2.2.1 UNII
26RU378B9V
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Abx464

2.3.2 Depositor-Supplied Synonyms

1. Abx-464

2. Abx464

3. Obefazimod

4. 1258453-75-6

5. Spl-464

6. Obefazimod [usan]

7. 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine

8. 26ru378b9v

9. 2-quinolinamine, 8-chloro-n-(4-(trifluoromethoxy)phenyl)-

10. Obefazimod [inn]

11. Unii-26ru378b9v

12. Schembl1705888

13. Abx-464 [who-dd]

14. Chembl4297344

15. Gtpl11698

16. Ex-a3322

17. Who 12112

18. Db14828

19. Mmv1581032

20. Sb18690

21. Ac-35811

22. Bs-14770

23. Abx464(abx-464;abx 464)

24. Hy-100870

25. Cs-0020537

26. S0076

27. A16912

28. D84095

29. Q27896117

2.4 Create Date
2011-01-31
3 Chemical and Physical Properties
Molecular Weight 338.71 g/mol
Molecular Formula C16H10ClF3N2O
XLogP35.9
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count6
Rotatable Bond Count3
Exact Mass338.0433751 g/mol
Monoisotopic Mass338.0433751 g/mol
Topological Polar Surface Area34.2 Ų
Heavy Atom Count23
Formal Charge0
Complexity388
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty